<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04824209</url>
  </required_header>
  <id_info>
    <org_study_id>0094485</org_study_id>
    <nct_id>NCT04824209</nct_id>
  </id_info>
  <brief_title>Serum Pro-Diabetes Inflammation Biomarkers in Patients With Apical Periodontitis.</brief_title>
  <official_title>Evaluation of Serum Markers of Pro-diabetes Inflammation in Patients With Chronic Apical Periodontitis Before and After Endodontic Treatment.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Turin, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Turin, Italy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Inflammation is a common factor of chronic periodontitis and diabetes. However, to date,&#xD;
      there is no scientific evidence supporting a causal effect of the inflammation created by&#xD;
      apical periodontitis on the onset of insulin resistance and on metabolic derangement in the&#xD;
      condition of pre-diabetes or diabetes.&#xD;
&#xD;
      A case control study has been designed in order to evaluate serum levels of pro-diabetes&#xD;
      inflammation factors in a sample of healthy patients between 25 and 55 years of age, with or&#xD;
      without apical periodontitis,before endodontic treatment and at 6 and 12 months&#xD;
      post-treatment. The aim of the study is to evaluate any relation between the presence of&#xD;
      chronic endodontic lesions and pro-diabetes inflammation factors that can promote the onset&#xD;
      of insulin resistance, and whether endodontic treatment can reduce these factors, thus&#xD;
      preventing a pro-diabetes/diabetes status.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Healthy, consenting and informed patients of both gender under 55 years of age with apical&#xD;
      periodontitis will be enrolled as cases. Healthy, consenting and informed patients of both&#xD;
      gender under 55 years of age without apical periodontitis will be enrolled as control. The&#xD;
      study has been designed to assess the serum level of lipopolysaccharide-binding protein&#xD;
      (LBP), TNF-α, IL-1β, IL-6, IL-8 and the platelet factor 4 (PF4) by ELISA assay. PF4 will be&#xD;
      dosed also in platelets.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 9, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Variation in pro-diabetes inflammation markers over time upon endodontic intervention.</measure>
    <time_frame>Baseline serum levels of selected pro-diabetes inflammation markers in control group and AP group.</time_frame>
    <description>Dosage of Lipopolysaccharide Binding Protein (LPB) (µg/mL), TNF-α, IL-1β, IL-6, IL-8 (pg/mL) and platelet factor 4 (PF4) (ng/mL) in serum and PF4 in platelets (ng/10^6 platelets) by ELISA assay.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Variation in pro-diabetes inflammation markers over time upon endodontic intervention.</measure>
    <time_frame>Serum levels of selected pro-diabetes inflammation markers at 6 months after endodontic treatment and in control group.</time_frame>
    <description>Dosage of Lipopolysaccharide Binding Protein (LPB) (µg/mL), TNF-α, IL-1β, IL-6, IL-8 (pg/mL) and platelet factor 4 (PF4) (ng/mL) in serum and PF4 in platelets (ng/10^6 platelets) by ELISA assay.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Variation in pro-diabetes inflammation markers over time upon endodontic intervention.</measure>
    <time_frame>Serum levels of selected pro-diabetes inflammation markers at 12 months after endodontic treatment and in control group.</time_frame>
    <description>Dosage of Lipopolysaccharide Binding Protein (LPB) (µg/mL), TNF-α, IL-1β, IL-6, IL-8 (pg/mL) and platelet factor 4 (PF4) (ng/mL) in serum and PF4 in platelets (ng/10^6 platelets) by ELISA assay.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Apical Periodontitis</condition>
  <condition>Insulin Resistance</condition>
  <condition>PreDiabetes</condition>
  <condition>Diabetes; Stable</condition>
  <arm_group>
    <arm_group_label>AP group</arm_group_label>
    <description>Healthy patients between 25-55 years with Apical Periodontitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <description>Healthy patients between 25-55 years without Apical Periodontitis</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood Sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Dental Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  25-55 years, healthy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  over 55 years, with systemic diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Damiano Pasqualini, DDS Ass Pro</last_name>
    <role>Principal Investigator</role>
    <affiliation>Endodontics, Department of Surgical Sciences - Univeristy of Turin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Damiano Pasqualini, DDS Ass Prof</last_name>
    <phone>+39 011670</phone>
    <phone_ext>1569</phone_ext>
    <email>damiano.pasqualni@unito.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Oncology - University of Turin</name>
      <address>
        <city>Turin</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Endodontics, Department of Surgical Sciences - Univeristy of Turin</name>
      <address>
        <city>Turin</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Damiano Pasqualini, DDS Ass Prof</last_name>
      <phone>+39 011670</phone>
      <phone_ext>1569</phone_ext>
      <email>damiano.pasqualini@unito.it</email>
    </contact>
    <contact_backup>
      <phone>+39 335451070</phone>
      <email>damiano.pasqualini@unito.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 16, 2021</study_first_submitted>
  <study_first_submitted_qc>March 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>March 26, 2021</last_update_submitted>
  <last_update_submitted_qc>March 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endodontics</keyword>
  <keyword>Apical Periodontitis</keyword>
  <keyword>Insulin Resistance</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Pro-Diabetes Inflammation Markers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Periapical Periodontitis</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

